David Marek
2020 - Axsome Therapeutics
In 2020, David Marek earned a total compensation of $2.5M as Former Chief Commercial Officer at Axsome Therapeutics, a 17% decrease compared to previous year.
Compensation breakdown
| Option Awards | $1,133,385 |
|---|---|
| Salary | $385,000 |
| Stock Awards | $392,387 |
| Other | $544,375 |
| Total | $2,455,147 |
Marek received $1.1M in option awards, accounting for 46% of the total pay in 2020.
Marek also received $385K in salary, $392.4K in stock awards and $544.4K in other compensation.
Rankings
In 2020, David Marek's compensation ranked 4,634th out of 13,090 executives tracked by ExecPay. In other words, Marek earned more than 64.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,634 out of 13,090 | 65th |
Division Manufacturing | 1,885 out of 5,621 | 67th |
Major group Chemicals And Allied Products | 738 out of 2,254 | 67th |
Industry group Drugs | 633 out of 1,954 | 68th |
Industry Pharmaceutical Preparations | 477 out of 1,459 | 67th |
Pay ratio
| David Marek's Pay | $2,455,147 |
|---|---|
| Median Employee's Pay | $299,771 |
| Pay Ratio | 8to 1 |
In 2020, the annual total compensation of David Marek was $2,455,147.
The annual total compensation of the median employee at Axsome Therapeutics was $299,771.
The ratio of David Marek's pay to the pay of median employee was therefore 8 to one.
Source: SEC filing on April 23, 2021.
Marek's colleagues
We found three more compensation records of executives who worked with David Marek at Axsome Therapeutics in 2020.